# McDonald's Corporation (MCD) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-27  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/MCD/thesis · /stocks/MCD/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: MCD
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-05-27
---

### Step 04 — Financial Quality & Adversarial Sweep: McDonald's Corporation (MCD)

#### Key Findings
- McDonald's financial statements are **high quality**. As a large-cap S&P 500 company audited by Ernst & Young, disclosures are comprehensive, and the franchise model makes earnings highly cash-generative and difficult to obscure.
- The most significant statement-quality issue is the **negative stockholders' equity (-$1.8B)** which can mislead less sophisticated investors — this is structural (cumulative buybacks exceeding retained earnings), not a solvency warning [S1].
- The Adversarial Research Sweep identified: (1) ongoing E. coli litigation; (2) franchisee labor practice lawsuits; (3) historical antitrust settlement ($26M); and (4) ESG controversy over plastic/packaging. None are material to core investment thesis [S2].
- SBC is modest ($165M in FY2025 = 0.6% of revenue) — not a meaningful earnings quality concern [S1].

#### Implications for Thesis and Valuation
- The primary "financial quality" risk at McDonald's is not accounting manipulation but rather **cash flow allocation discipline** — the company returns $7B/year to shareholders but carries $40B in debt at rising rates. If interest rates stay elevated, the interest expense line (~$1.6B/year) becomes a meaningful EPS headwind.
- Restructuring charges ("Accelerating the Organization" program) are a recurring one-time item — analysts should normalize these for clean EPS comparisons.

#### Objective
Assess the quality and reliability of McDonald's financial statements; identify any adversarial research findings, litigation, or accounting adjustments material to the investment thesis.

#### Narrative Analysis

##### Income Statement Quality

**Revenue recognition:** McDonald's revenue recognition is straightforward for a franchise business. Franchise fees are recognized ratably over the franchise agreement term. Royalties are recognized as percentage of sales as earned. Company-operated sales are recognized at point of sale. No aggressive revenue recognition practices identified [S1].

**Segment reporting:** Three-segment structure (U.S., IOM, IDL) is well-disclosed with franchised revenues, company-operated revenues, and operating income by segment. No evidence of segment manipulation or unusual inter-segment transactions [S1].

**Non-GAAP adjustments:** McDonald's occasionally presents adjusted EPS excluding: (1) restructuring charges ("Accelerating the Organization" initiative); (2) gains/losses on restaurant sales and other asset dispositions; (3) certain tax items. These adjustments are well-disclosed and generally accepted by the Street [S1].

##### Restructuring / Accelerating the Organization
McDonald's initiated a restructuring program ("Accelerating the Organization") in 2024 to streamline corporate structure and reduce SG&A. Charges have flowed through the P&L in FY2024-2025 and are expected to continue through FY2027. The restructuring is aimed at reducing headcount in corporate and shared services to achieve ~$0.5B in annual SG&A savings by FY2026-2027. These are real costs that investors should include in their full-cycle analysis, not indefinitely adjust away [S1].

##### Balance Sheet Quality

**Negative equity (judgment: structural, not distressed):** McDonald's book equity has been negative since FY2017 due to cumulative share repurchases exceeding retained earnings. At YE2025, equity = -$1.8B on $59.5B in total assets. This is standard for highly leveraged franchise operators with predictable cash flows — see also: Home Depot, Yum! Brands, and Starbucks with similar structures. The $40B in long-term debt is backed by $139B in systemwide sales, ~$12B EBIT, and ~$10B OCF [S1].

**Goodwill ($3.35B):** Modest relative to assets, primarily from franchise acquisitions (e.g., buying back licenses from developmental licensees to convert to conventional franchises). Not a material impairment risk [S1].

**PP&E ($42.8B):** Represents McDonald's real estate and leasehold assets — the physical footprint of restaurant properties. This is marked at book value (cost less accumulated depreciation); fair market value of McDonald's real estate portfolio is estimated significantly higher by real estate analysts [S1].

##### Cash Flow Quality

Free cash flow ($7.2B in FY2025) is clean and directly verifiable: OCF $10.6B less CapEx $3.4B. No evidence of working capital manipulation or unusual timing of cash receipts/payments [S1].

SBC was $165M in FY2025 (0.6% of revenue). When added back to FCF for a full economic picture, SBC-diluted FCF = ~$7.1B. Immaterial adjustment [S1].

##### Adversarial Research Sweep

**Active Litigation:**
1. **E. coli outbreak civil suits (2024–ongoing):** Class action and individual suits filed by victims of the October 2024 Quarter Pounder E. coli outbreak. Estimated damages: $10–50M range (manageable). Taylor Farms (onion supplier) is co-defendant and likely to bear meaningful proportion of liability. No material accrual disclosed as of FY2025 10-K [S2].

2. **Labor practice / joint employer litigation:** Ongoing legal battles regarding whether McDonald's should be classified as a joint employer of franchisee workers, which would expose it to significant liability for wage violations at franchisee locations. The NLRB joint-employer rule reversal under current administration reduces near-term risk significantly [S2].

3. **Antitrust settlement (2017):** McDonald's paid $26M to settle claims from workers alleging the company restricted inter-franchise hiring ("no-poach" agreements). This is historical and resolved [S2].

4. **International regulatory actions:** Various EU markets have ongoing inquiries related to advertising practices (particularly to children), plastic packaging requirements, and minimum pricing rules. None individually material but collectively represent ongoing regulatory compliance cost [S2].

**Short Interest / Bearish Research:**
- Short interest is low (~1.3–1.6% of float) — MCD is not a significant short target
- Primary bear cases in research (covered more fully in Step 12) center on: leverage + interest expense, slower comp recovery, and valuation premium

**ESG / Reputational:**
- Plastic packaging commitments: McDonald's committed to 100% sustainable packaging by 2025; partially met; ongoing scrutiny from environmental NGOs
- Animal welfare: Ongoing pressure from animal welfare advocates on cage-free eggs and antibiotic-free chicken timelines
- Nutrition/obesity: Long-standing criticism; partially addressed by menu transparency efforts
None of these are investment-thesis-level risks but add to regulatory compliance costs [S2].

**No short reports, SEC enforcement actions, or auditor disagreements identified.**

#### Evidence and Sources
- Financial data from 10-K FY2025 [S1]
- Litigation information from 10-K risk factors, legal proceedings section [S1]
- E. coli background from news sources [S2]
- Short interest from MarketBeat [S3]

#### Assumption Register Updates
- A05: Restructuring charges expected ~$100–150M/year through FY2027; model should normalize [ESTIMATE, LOW confidence on timing]

#### Tables and Calculations

##### Earnings Quality Scorecard
| Dimension | Rating | Notes |
|-----------|--------|-------|
| Revenue recognition | HIGH | Straightforward franchise/sales model |
| Earnings sustainability | HIGH | FCF > Net Income in all years; cash-generative |
| Balance sheet transparency | HIGH | Negative equity is structural and disclosed |
| SBC as % of revenue | LOW (0.6%) | Immaterial |
| Non-GAAP adjustments | MODERATE | Restructuring charges are recurring |
| Litigation risk | LOW-MOD | E. coli suits + labor; manageable |
| Auditor | HIGH | Ernst & Young; no disagreements |
| Overall | **HIGH QUALITY** | — |

##### Key Adjustments for Clean EPS
| Item | FY2024 | FY2025 | Treatment |
|------|--------|--------|-----------|
| Reported EPS | $11.39 | $11.95 | Base |
| Restructuring charges (after-tax est.) | +$0.30 | +$0.20 | Add back |
| Gains on asset sales (after-tax) | -$0.10 | -$0.05 | Deduct |
| Adjusted EPS (est.) | ~$11.59 | ~$12.10 | Clean comparison |

#### Source Index
| Source Tag | Document or URL | Section | Date | Notes |
|------------|----------------|---------|------|-------|
| [S1] | 10-K FY2025 (accession 0000063908-26-000035) | Balance Sheet, Legal Proceedings, MD&A | 2026-02-24 | Primary financial quality source |
| [S2] | News / web search | E.coli litigation, labor suits, regulatory | 2026-05-27 | Adversarial research sweep |
| [S3] | MarketBeat / web | Short interest data | 2026-05-27 | Short interest ~1.3–1.6% |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/MCD/fundamental

## Navigation

- Overview: /stocks/MCD
- Financials (this page): /stocks/MCD/financials
- Thesis: /stocks/MCD/thesis
- Investment Memo: /stocks/MCD/memo
- Coverage universe: /stocks